RNAi and CRISPR Screening, Drug Target and Biomarker Discovery

RNAi and CRISPR screening products and services. Characterize therapeutic targetsdrugs, and identify mechanism of action. Discover novel biomarkers.

OVERVIEW

The website cellecta.com presently has a traffic classification of zero (the smaller the more traffic). We have downloaded twenty pages within the web page cellecta.com and found fifty-five websites referring to cellecta.com. We were able to precure one contacts and locations for cellecta.com to help you connect with them. We were able to precure three public network sites linked to this website. The website cellecta.com has been online for nine hundred and fifty weeks, fifteen days, five hours, and fifty-five minutes.
Pages Parsed
20
Links to this site
55
Contacts
1
Addresses
1
Social Links
3
Online Since
Apr 2006

CELLECTA.COM TRAFFIC

The website cellecta.com is seeing variant amounts of traffic in the past the year.
Traffic for cellecta.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for cellecta.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for cellecta.com

Date Range

All time
This Year
Last Year
Last Month

CELLECTA.COM HISTORY

The website cellecta.com was first submitted to the registrar on April 18, 2006. This web page was changed on the date of April 19, 2014. It will go back on the market on the date of April 18, 2015. It is now nine hundred and fifty weeks, fifteen days, five hours, and fifty-five minutes young.
REGISTERED
April
2006
UPDATED
April
2014
EXPIRED
April
2015

WEBSITE MATURITY

18
YEARS
2
MONTHS
14
DAYS

LINKS TO CELLECTA.COM

Discovery On Target 2018

Small Molecules for Cancer Immunotherapy. Autoimmune and Inflammation Drug Targets.

Home - A WebsiteBuilder Website

is a discovery stage biotechnology company seeking novel anti-cancer and anti-aging drugs.

The Molecular Medicine Tri Conference 2015

Register Early and Save! Event at a Glance. Genomic Sample Prep and Biomarker Assay Development. Molecular Diagnostics for Infectious Disease New. Genomic Sample Prep and Biomarker Assay Development.

World Preclinical Congress Europe

Where Preclinical Minds Meet Discovery Technologies. The World Preclinical Congress Europe. To innovate traditional drug discovery by sharing ideas, showcasing new technologies, and fostering new collaborations. Preclinical Models for Cancer Immunotherapy and Combinations. Optimizing Leads and Predicting Drug Toxicity. Use of CRISPR and RNAi for Drug Discovery.

World Preclinical Congress

2017 Conference Streams and Agendas. 250 First Avenue, Suite 300.

WHAT DOES CELLECTA.COM LOOK LIKE?

Desktop Screenshot of cellecta.com Mobile Screenshot of cellecta.com Tablet Screenshot of cellecta.com

CONTACTS

Cellecta, Inc.

Karim Hyder

320 Logue Ave

Mountain View, CA, 94043

US

CELLECTA.COM SERVER

I found that a lone root page on cellecta.com took three thousand six hundred and seventy-nine milliseconds to download. We found a SSL certificate, so in conclusion our parsers consider cellecta.com secure.
Load time
3.679 sec
SSL
SECURE
IP
64.111.113.60

NAME SERVERS

ns1.bdm.microsoftonline.com
ns2.bdm.microsoftonline.com

FAVICON

SERVER SOFTWARE

We identified that cellecta.com is operating the Apache operating system.

SITE TITLE

RNAi and CRISPR Screening, Drug Target and Biomarker Discovery

DESCRIPTION

RNAi and CRISPR screening products and services. Characterize therapeutic targetsdrugs, and identify mechanism of action. Discover novel biomarkers.

PARSED CONTENT

The website had the following in the homepage, "CellTracker Barcode Cell Labeling Kits." I analyzed that the web site stated " CRISPR Human Genome-Wide Knockout Libraries." They also stated " Single-Module Human Genome-Wide CRISPR Library 80K. Three-Module Human Genome-Wide CRISPR Library 150K. CRISPRa CRISPRi Human Genome-Wide Libraries. CRISPR Mouse Genome-Wide Knockout Library. CRISPRa CRISPRi Mouse Genome-Wide Libraries. CRISPRtest Functional Cas9 Activity Kits Mammalian."

SEE OTHER WEB PAGES

Cellectar Biosciences Phospholipid Drug Conjugates PDCs for Targeted Delivery of Oncologic Payloads

Create is a multi-purpose WordPress theme that gives you the power to create many different styles of websites. Better Therapy Through Targeted Delivery. For Targeted Delivery of Oncologic Payloads.

Cellectar Biosciences Novel Agents for the Treatment and Diagnosis of Cancer

As seen in Science Translational Medicine. Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy. Read our latest publication in Neurosurgery. Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection.

cellectbudwig.com

Introduction to the Cellect-Budwig Protocol.

Radio Capelle Locomotive - Radio Capelle - Radio Capelle Locomotive

Saturday night out, nu op je radio! Klik hier om naar de programma pagina te gaan. Overal in Capelle in de ether via 105. En via de kabel 102. Of bel tijdens een live uitzending met 010-451 7777. Klik hier voor meer nieuws.

Home Cellectis

Next-Generation CAR T-Cells to Cure Cancer. A Future-defining Shift in Simplicity, Availability, and Cost-effectiveness. That can work for the largest number of patients. 75 granted patents and 443 applications. Global strategic partnerships with Pfizer, Servier, and leading Universities all over the world.